AKT1 and Obesity: Activation of hepatic AMPK signaling in a diet-induced obesity model reduces hepatic steatosis and downstream inflammation and fibrosis (Garcia et al., 2019), whereas activation of hepatic AKT reduces glucose production in the liver (Titchenell et al., 2016).